Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra Sells 12,219 Shares

Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra sold 12,219 shares of Privia Health Group stock in a transaction on Tuesday, April 30th. The stock was sold at an average price of $18.42, for a total transaction of $225,073.98. Following the sale, the chief executive officer now directly owns 261,640 shares in the company, valued at approximately $4,819,408.80. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Privia Health Group Stock Up 1.8 %

Shares of PRVA stock opened at $18.74 on Friday. The business has a 50 day moving average of $19.62 and a two-hundred day moving average of $21.12. Privia Health Group, Inc. has a 52 week low of $17.54 and a 52 week high of $30.15. The company has a market cap of $2.22 billion, a P/E ratio of 98.64, a PEG ratio of 2.56 and a beta of 0.81.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings results on Tuesday, February 27th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.02). The business had revenue of $440.80 million during the quarter, compared to the consensus estimate of $425.81 million. Privia Health Group had a return on equity of 3.97% and a net margin of 1.39%. The company’s revenue for the quarter was up 21.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.14 EPS. Analysts expect that Privia Health Group, Inc. will post 0.26 EPS for the current fiscal year.

Institutional Trading of Privia Health Group

A number of hedge funds and other institutional investors have recently made changes to their positions in PRVA. Park Place Capital Corp increased its stake in shares of Privia Health Group by 115.4% during the first quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock valued at $49,000 after acquiring an additional 1,335 shares during the period. Benjamin Edwards Inc. raised its stake in shares of Privia Health Group by 44.9% in the 4th quarter. Benjamin Edwards Inc. now owns 3,239 shares of the company’s stock worth $75,000 after buying an additional 1,003 shares in the last quarter. Covestor Ltd lifted its holdings in shares of Privia Health Group by 8.3% in the third quarter. Covestor Ltd now owns 6,703 shares of the company’s stock valued at $154,000 after buying an additional 514 shares during the period. Benjamin F. Edwards & Company Inc. bought a new position in Privia Health Group during the fourth quarter valued at about $158,000. Finally, International Assets Investment Management LLC grew its holdings in Privia Health Group by 2,721.7% during the fourth quarter. International Assets Investment Management LLC now owns 7,139 shares of the company’s stock worth $164,000 after acquiring an additional 6,886 shares during the period. 94.48% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on PRVA. Citigroup initiated coverage on Privia Health Group in a research report on Monday, April 22nd. They set a “buy” rating and a $25.00 target price on the stock. Truist Financial cut their target price on Privia Health Group from $32.00 to $28.00 and set a “buy” rating on the stock in a research report on Thursday, February 29th. Barclays initiated coverage on shares of Privia Health Group in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $22.00 price target for the company. TD Cowen decreased their price objective on shares of Privia Health Group from $30.00 to $26.00 and set an “outperform” rating for the company in a report on Friday, March 1st. Finally, UBS Group cut their target price on shares of Privia Health Group from $31.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, March 1st. Two analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $27.62.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.